Author Archives: Iqra Mumal, MSc

FDA Grants Fast Track Designation to PWS Potential Therapy LV-101

The U.S. Food and Drug Administration (FDA) has granted fast track designation to LV-101 (intranasal carbetocin), a treatment candidate for people with Prader-Willi syndrome (PWS). This designation is granted to promising therapies intended to treat serious diseases with unmet medical needs. It aims to quicken treatment development by…

Daily Probiotic Reduces Abdominal Fat and Insulin Resistance in Children with PWS, Study Finds

Daily consumption of a common probiotic significantly lowered the percentage of abdominal fat, improved insulin resistance, and reduced social withdrawal in patients with Prader-Willi syndrome, a study has found. The research, “Effects of Bifidobacterium animalis subsp. lactis on children with Prader-Willi syndrome: A randomized, double-blind, placebo-controlled, crossover trial,”…

Bariatric Surgery a Feasible Option for Adolescents with Prader-Willi, Case Report Suggests

With careful multidisciplinary evaluation and psychosocial support, adolescents with Prader-Willi syndrome (PWS) with severe obesity can undergo bariatric surgery with successful results, a case report suggests. The study, “Laparoscopic sleeve gastrectomy in an adolescent with Prader-Willi syndrome: psychosocial implications,” was published in the journal Nutrition. PWS is the most…

Surgery Can Successfully Treat Obstructive Sleep Apnea, Malocclusion in PWS, Case Study Reports

Patients with Prader-Willi syndrome (PWS) who develop significant obstructive sleep apnea and malocclusion can be successfully treated using surgical methods, according to a case report. The case study, “Orthognathic Correction in Prader-Willi Syndrome: Occlusion and Sleep Restored,” was published in The Cleft Palate-Craniofacial Journal. Prader-Willi children…